What Fueled The Previous Growth In The Yellow Fever Vaccine Market?
The yellow fever vaccine market has seen considerable growth due to a variety of factors.
• The yellow fever vaccine market has seen strong growth in recent years. It will increase from $4.54 billion in 2024 to $4.79 billion in 2025, at a CAGR of 5.4%.
The growth is driven by global immunization campaigns, the implementation of international health regulations, mass vaccination efforts, and advances in vaccine production technology.
What Can Be Expected from the Yellow Fever Vaccine Market Size?
The yellow fever vaccine market is expected to maintain its strong growth trajectory in upcoming years.
• The yellow fever vaccine market is expected to grow at a strong pace, reaching $5.84 billion by 2029 at a CAGR of 5.1%.
Growth is fueled by increased collaboration, integration into routine vaccination schedules, monitoring and surveillance, greater involvement of the private sector, and the use of digital technologies for tracking vaccines. Trends include diversification of vaccine formats, pandemic preparedness, regulatory changes, improvements in healthcare infrastructure, and consumer education.
What Are the Critical Driver Fuelling The Yellow Fever Vaccine Market's Growth?
The yellow fever vaccine market is anticipated to be bolstered by the rise in international travel. Defined as the crossing of national boundaries by individuals for reasons such as tourism, business, or personal affairs, international travel is witnessing a surge due to an increase in global connectivity, economic expansion, and the easing of travel restrictions following the pandemic. It is either mandatory or advised for travelers journeying to areas where yellow fever is prevalent to get vaccinated to avoid infection and adhere to global health guidelines. This was exemplified in January 2024 when, as reported by the Spain-based World Tourism Organization, the number of international tourists reached 1.286 billion globally in 2023, compared to 960 million in 2022 – an increase of 326 million. As a result, the escalation in international travel is contributing to the rise of the yellow fever vaccine market.
How Is The Yellow Fever Vaccine Market segmented?
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Pre-Book The Yellow Fever Vaccine Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Yellow Fever Vaccine Market?
Leading firms in the yellow fever vaccine market are centering their efforts on creating next-generation vaccinations, such as T-cell adaptive booster vaccines, in response to the rising worldwide vaccine demand. These are specialized vaccines meant to augment the memory T-cell response of our immune system, thus providing extended and robust defense against particular pathogens. For example, in April 2022, UK-based biotech firm, Emergex Vaccines Holding Limited, joined forces with ATCC, a non-profit organization based in the US that supplies reference microorganisms, cell lines, and other research and development materials, to launch CD8+ T-cell adaptive vaccines. These are tailored explicitly for yellow fever and are devised to incite a robust cytotoxic T-cell response, crucial for spotting and exterminating virus-infected cells. By fostering the generation of memory CD8+ T-cells, these vaccines bestow enduring and robust immunity. They target the cellular immune response instead of simply antibody production, providing holistic protection against yellow fever and potentially escalating effectiveness in people with varied immune profiles.
Who Are the Key Players In The Yellow Fever Vaccine Market?
Major companies operating in the yellow fever vaccine market are:
• Merck and Co Inc.
• Sanofi S.A.
• GSK plc
• Takeda Pharmaceutical Company
• Lonza Group Ag
• WuXi Biologics
• Novavax Inc.
• Beijing Tiantan Biological
• Bavarian Nordic A/S
• Valneva SE
• Biological E. Limited
• Bio-Manguinhos
• Instituto Butantan
• Bio Farma
• Panacea Biotec
• Biovac
• Institut Pasteur de Dakar
• Ology Bioservices
• Gavi
• Wuhan Institute of Biological Products
• PnuVax Incorporated
• iBio Inc.
What Is The Most Dominant Region In The Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
